(责任编辑：徐自立) 中国经济网北京2月6日讯 重庆银行(601963.SH)今日股价收报10.68元，跌幅1.93%。今日，银行 板块跌0.21%，重庆银行为该板块跌幅最大的上市公司。 ...

Group 1 - The core point of the article is that Chongqing Bank has launched a new fixed-income financial product, the Yangtze·Xianghui Public Net Value Type Closed-end 2026 Phase 2, with a fundraising period from February 5, 2026, to February 12, 2026 [1] - The minimum subscription amount for investors is set at 10,000 yuan, with a planned issuance volume of 500 million yuan [1] - The product has a risk rating of medium-low and a duration of 452 days, with a performance benchmark of 2.15% to 3.00% annualized [1]

每经AI快讯，港股内银股多数上扬。截至发稿，重庆银行(01963.HK)涨3.6%，报8.05港元；天津银行 (01578.HK)涨2.53%，报2.43港元；招商银行(03968.HK)涨2.44%，报48.66港元；邮储银行(01658.HK)涨 2.15%，报5.23港元。 ...

消息面上，近日，中国人民银行召开2026年信贷市场工作会议。会议要求，做好2026年信贷市场工作要 准确把握"十五五"时期经济金融形势变化，统筹发展和安全，不断加强对重大战略、重点领域和薄弱环 节的优质金融服务。市场人士分析，此次央行信贷市场工作会议有望为银行板块带来多维度利好。 内银股多数上扬，截至发稿，重庆银行（601963）(01963)涨3.6%，报8.05港元；天津银行(01578)涨 2.53%，报2.43港元；招商银行（600036）(03968)涨2.44%，报48.66港元；邮储银行（601658）(01658) 涨2.15%，报5.23港元。 中泰证券（600918）此前指出，开门红投放较好，全年投放继续前置，优质区域银行全年信贷增量预计 可维持同比多增。对公新发利率环比小幅下降，降幅或小于去年，零售新发利率趋稳（新发按揭利率连 续三个季度维持在3.06%），即使降息预期下，预计息差降幅仍同比收窄。利息收入支撑下，预计全年 银行营收利润依然稳健。当前板块业绩确定性、稳定性强，股息率高，具备配置性价比。 ...

中泰证券此前指出，开门红投放较好，全年投放继续前置，优质区域银行全年信贷增量预计可维持同比 多增。对公新发利率环比小幅下降，降幅或小于去年，零售新发利率趋稳（新发按揭利率连续三个季度 维持在3.06%），即使降息预期下，预计息差降幅仍同比收窄。利息收入支撑下，预计全年银行营收利 润依然稳健。当前板块业绩确定性、稳定性强，股息率高，具备配置性价比。 智通财经APP获悉，内银股多数上扬，截至发稿，重庆银行(01963)涨3.6%，报8.05港元；天津银行 (01578)涨2.53%，报2.43港元；招商银行(03968)涨2.44%，报48.66港元；邮储银行(01658)涨2.15%，报 5.23港元。 消息面上，近日，中国人民银行召开2026年信贷市场工作会议。会议要求，做好2026年信贷市场工作要 准确把握"十五五"时期经济金融形势变化，统筹发展和安全，不断加强对重大战略、重点领域和薄弱环 节的优质金融服务。市场人士分析，此次央行信贷市场工作会议有望为银行板块带来多维度利好。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 呈交日期: 2026年2月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01963 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,579,020,812 | RMB | | | 1 RMB | | 1,579,020,812 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 1,579,020,812 | RMB | | | 1 RMB | | 1,579,020,812 | | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 ( ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 重慶銀行股份有限公司 呈交日期: 2026年2月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01963 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,579,020,812 | RMB | | | 1 RMB | | 1,579,020,812 | | 增加 / 減少 (-) | | | | | | | RMB | | | | 本月底結存 | | | 1,579,020,812 | RMB | | | 1 RMB | | 1,579,020,812 | | 2. 股份分類 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 601963 | 重庆银行 | 10.18 | -1.83% | 12.29万 | 1.25亿 | | 601838 | 成都银行 | 15.82 | -1.62% | 44.70万 | 7.10亿 | | 601665 | 齐鲁银行 | 5.64 | -1.57% | 74.37万 | 4.21亿 | | 601169 | 北京银行 | 5.28 | -1.31% | 196.28万 | 10.39亿 | | 601229 | 上海银行 | 9.27 | -1.28% | 53.77万 | 4.98亿 | | 601577 | 长沙银行 | 9.56 | -0.93% | 19.60万 | 1.87亿 | | 600928 | 西安银行 | 3.69 | -0.81% | 24.44万 | 9033.50万 | | 601997 | 贵阳银行 | 5.69 | -0.70% | 42.61万 | 2.43亿 | | 616009 | 江苏银行 | ...

Report Summary - The report presents the top ten convertible bonds in February 2026, along with detailed information about the issuing companies, including their business scope, financial data, and key attractions [1][6]. Top Ten Convertible Bonds in February 2026 1. Zhongte Convertible Bond - Rating: AAA; 1 - end closing price: 128.153 yuan; conversion premium rate: 73.5%; PE - TTM of the underlying stock: 14.75 [1][8]. - Company: A global leader in special - steel manufacturing with an annual production capacity of about 20 million tons. It has a complete industrial chain and multiple production bases [13]. - Financials: In 2024, revenue was 109.203 billion yuan (-4.22% yoy), net profit attributable to shareholders was 5.126 billion yuan (-10.41% yoy). In the first three quarters of 2025, revenue was 81.206 billion yuan (-2.75% yoy), net profit attributable to shareholders was 4.33 billion yuan (+12.88% yoy) [13]. - Highlights: It is one of the world's most comprehensive special - steel enterprises, with high market shares in core products. It has strong cost - control and is seeking external expansion [14]. 2. Shanlu Convertible Bond - Rating: AAA; 1 - end closing price: 128.472 yuan; conversion premium rate: 54.45%; PE - TTM of the underlying stock: 4.32 [6][8]. - Company: Focused on road and bridge construction and maintenance, and expanding into other fields. It has a complete business system [31]. - Financials: In 2024, revenue was 71.348 billion yuan (-2.3% yoy), net profit attributable to shareholders was 2.322 billion yuan (+1.47% yoy). In the first three quarters of 2025, revenue was 41.354 billion yuan (-3.11% yoy), net profit attributable to shareholders was 1.41 billion yuan (-3.27% yoy) [31]. - Highlights: It has the "China Special Valuation" concept, and its balance sheet and potential orders may improve. It may benefit from infrastructure plans in Shandong and the Belt and Road Initiative [32]. 3. Hebang Convertible Bond - Rating: AA; 1 - end closing price: 153.399 yuan; conversion premium rate: 21.26%; PE - TTM of the underlying stock: -230.95 [6][8]. - Company: With a diversified business layout in chemicals, agriculture, and photovoltaics, it has expanded from a single - product business [44]. - Financials: In 2024, revenue was 8.547 billion yuan (-3.13% yoy), net profit attributable to shareholders was 31 million yuan (-97.55% yoy). In the first three quarters of 2025, revenue was 5.927 billion yuan (-13.02% yoy), net profit attributable to shareholders was 93 million yuan (-57.93% yoy) [44]. - Highlights: Its liquid methionine production has high profitability and is a major profit contributor [47]. 4. Huayuan Convertible Bond - Rating: AA -; 1 - end closing price: 145.282 yuan; conversion premium rate: 9.47%; PE - TTM of the underlying stock: 32.14 [6][8]. - Company: Focused on building a complete vitamin D3 industrial chain, with products in the vitamin and pharmaceutical sectors [58]. - Financials: In 2024, revenue was 1.243 billion yuan (+13.58% yoy), net profit attributable to shareholders was 309 million yuan (+60.76% yoy). In the first three quarters of 2025, revenue was 936 million yuan (-0.2% yoy), net profit attributable to shareholders was 234 million yuan (-3.07% yoy) [58]. - Highlights: It is a leader in certain products, and is expanding its product portfolio and has achievements in pharmaceutical R & D [59]. 5. Xingye Convertible Bond - Rating: AAA; 1 - end closing price: 123.691 yuan; conversion premium rate: 40.16%; PE - TTM of the underlying stock: 5.11 [6][8]. - Company: One of the first joint - stock commercial banks in China, evolving into a modern financial service group [72]. - Financials: In 2024, revenue was 212.226 billion yuan (+0.66% yoy), net profit attributable to shareholders was 77.205 billion yuan (+0.12% yoy). In the first three quarters of 2025, revenue was 161.234 billion yuan (-1.82% yoy), net profit attributable to shareholders was 63.083 billion yuan (+0.12% yoy) [72]. - Highlights: It has stable asset quality and scale growth, with a large customer base [73]. 6. Aima Convertible Bond - Rating: AA; 1 - end closing price: 126.979 yuan; conversion premium rate: 60.87%; PE - TTM of the underlying stock: 10.97 [6][8]. - Company: The leading enterprise in the electric two - wheeler industry, with self - developed and produced products [82]. - Financials: In 2024, revenue was 21.606 billion yuan (+2.71% yoy), net profit attributable to shareholders was 1.988 billion yuan (+5.68% yoy). In the first three quarters of 2025, revenue was 21.093 billion yuan (+20.78% yoy), net profit attributable to shareholders was 1.907 billion yuan (+22.78% yoy) [82]. - Highlights: It may benefit from government subsidies and the implementation of new national standards, and has potential for improving gross margin [83]. 7. Chongyin Convertible Bond - Rating: AAA; 1 - end closing price: 128.332 yuan; conversion premium rate: 16.22%; PE - TTM of the underlying stock: 6.55 [6][8]. - Company: An early - established local joint - stock commercial bank in the upper reaches of the Yangtze River and Southwest China, with a wide range of business operations [92]. - Financials: In 2024, revenue was 13.679 billion yuan (+3.54% yoy), net profit attributable to shareholders was 5.117 billion yuan (+3.8% yoy). In the first three quarters of 2025, revenue was 11.74 billion yuan (+10.4% yoy), net profit attributable to shareholders was 4.879 billion yuan (+10.19% yoy) [92]. - Highlights: It may benefit from the development of the Chengdu - Chongqing economic circle, has stable asset growth, and has a good risk - control strategy [93][96]. 8. Tianye Convertible Bond - Rating: AA+; 1 - end closing price: 141.695 yuan; conversion premium rate: 26.15%; PE - TTM of the underlying stock: 163.89 [6][8]. - Company: A leading enterprise in the chlor - alkali chemical industry in Xinjiang, with an integrated circular economy industrial chain [105]. - Financials: In 2024, revenue was 11.156 billion yuan (-2.7% yoy), net profit attributable to shareholders was 68 million yuan (+108.83% yoy). In the first three quarters of 2025, revenue was 7.97 billion yuan (+2.2% yoy), net profit attributable to shareholders was 7 million yuan (-28.79% yoy) [105]. - Highlights: It benefits from cost - reduction in raw materials and plans to increase dividend frequency, and its group is promoting coal - mine projects [107]. 9. Aorui Convertible Bond - Rating: AA -; 1 - end closing price: 160.557 yuan; conversion premium rate: 39.57%; PE - TTM of the underlying stock: 27.45 [6][8]. - Company: Focused on the R & D, production, and sales of complex APIs and formulations, leading in certain technical fields [120]. - Financials: In 2024, revenue was 1.476 billion yuan (+16.89% yoy), net profit attributable to shareholders was 355 million yuan (+22.59% yoy). In the first three quarters of 2025, revenue was 1.237 billion yuan (+13.67% yoy), net profit attributable to shareholders was 354 million yuan (+24.58% yoy) [120]. - Highlights: It is optimizing its distribution network, expanding the market for its formulation products, and has high - quality customer resources [121]. 10. Yushui Convertible Bond - Rating: AAA; 1 - end closing price: 128.343 yuan; conversion premium rate: 35.36%; PE - TTM of the underlying stock: 26.26 [6][8]. - Company: The largest water supply and drainage integrated enterprise in Chongqing, with a monopoly position in the local market [134]. - Financials: In 2024, revenue was 6.999 billion yuan (-3.52% yoy), net profit attributable to shareholders was 785 million yuan (-27.88% yoy). In the first three quarters of 2025, revenue was 5.568 billion yuan (+7.21% yoy), net profit attributable to shareholders was 779 million yuan (+7.1% yoy) [134]. - Highlights: It has a high market share, is expanding its business scope, and has achieved cost - control through intelligent applications [135]. Related Reports - "Pricing of Naipu Convertible Bond 02: First - day conversion premium rate of 28% - 33%", released on January 27, 2026 [3]. - "Pricing of Shangtai Convertible Bond: First - day conversion premium rate of 40% - 45%", released on January 27, 2026 [3]. - "Pricing of Lianrui Convertible Bond: First - day conversion premium rate of 43% - 48%", released on January 15, 2026 [3]. - "Outlook for US Inflation in 2026: High at first, then low, overall controllable", released on January 12, 2026 [3].

重庆银行股份有限公司 首次公开发行部分限售股上市流通公告 本行董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性依法承担法律责任。 证券代码：601963 证券简称：重庆银行 公告编号：2026-004 重要内容提示： 可转债代码：113056 可转债简称：重银转债 ● 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为3,463,381股。 登录新浪财经APP 搜索【信披】查看更多考评等级 本次股票上市流通总数为3,463,381股。 ● 本次股票上市流通日期为2026年2月5日。 一、本次限售股上市类型 经中国证券监督管理委员会《关于核准重庆银行股份有限公司首次公开发行股票的批复》（证监许可 〔2020〕3511号）核准，本行向社会首次公开发行人民币普通股（A股）股票347,450,534股，并于2021 年2月5日在上海证券交易所挂牌上市。 首次公开发行股票后，本行总股本为3,474,505,339股，其中：有限售条件A股股份为1,548,033,993股， 无限售条件A股股份为347,450,534股，H股股份为1,579,020,8 ...